Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
There is unexplained weight loss or night sweats
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrm syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Preclinical Evidence Only Evidence is primarily based on cells, tissues, or animal models
Her energy levels increased, her tremors reduced, and she regained a healthy weight
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
